NASDAQ:AMPH

Amphastar Pharmaceuticals Earning Date

USA |NASDAQ |USD

AMPH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 4, 2021 Sep 2021 $0.24 $0.21 $0.15
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 4, 2021 Sep 2021 $103.24M $101.66M $83.43M

Amphastar Pharmaceuticals's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 2021.

AMPH Earnings Date & History Chart

AMPH Earnings & Revenue Forecast

AMPH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $0.29 $0.24 $0.46
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $1.01 $0.91 $1.23
Dec 2022 6 $1.40 $1.16 $1.90

AMPH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.29 $0.28 $0.30
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $1.01 $1.02 $0.99
Dec 2022 0 / 0 $1.40 $1.40 $1.36

AMPH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $109.63M $103.80M $119.75M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $417.47M $410.00M $429.55M
Dec 2022 5 $471.87M $452.80M $501.86M

AMPH Earnings Date & Revenue History

AMPH Earnings History

|
Show More
Show More

AMPH Revenue History

|
Show More
Show More

Amphastar Pharmaceuticals Next Earnings Date & Report

AMPH Next Earnings Date & Report Preview: Sep 2021 (FQ)

AMPH's next earnings date is Thursday, Nov 4, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Amphastar Pharmaceuticals's next quarterly earnings is $0.24, with a low EPS estimation of $0.22, and a high estimation of $0.29.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.24, the last 2 month trend is $0.24, and the 3 month trend is $0.23.

Based on 5 analysts, the average revenue estimation is $103.24M, with a low revenue estimation of $101.90M, and a high estimation of $105.12M.

Amphastar Pharmaceuticals Previous Earnings Dates & Reports

AMPH Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Amphastar Pharmaceuticals's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

AMPH's earnings per share (EPS) was $0.21, beating the consensus analysts forecast of $0.21 by 0.82%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -22.22%, and higher than the same period a year before (Jun 2020) by 31.25%.

Revenues were $101.66M, better than the forecast of $101.38M by 0.28%, down by -1.32% from the previous quarter , and up by 18.48% from the same period last year.

The company reported a net income of $8.62M.

Free cash flow for the quarter was $62.02M , compared to $15.21M last quarter and $19.20M a year before.

AMPH ended the quarter with $46.61M in total debt, a decrease of -3.31% compared to the previous quarter, and a decrease of -7.10% compared to the same quarter a year before.

AMPH Previous Earnings Date & Report Recap: Dec 2020 (FY)

Amphastar Pharmaceuticals's previous annual earnings date was Mar 15, 2021 for its fiscal year ended Dec 31, 2020.

AMPH's earnings per share (EPS) was $0.64, beating the consensus analysts forecast of $0.60 by 6.67% , and higher than the previous year's EPS (Dec 2019) by 82.86%.

Revenues were $349.85M, better than the forecast of $342.70M by 2.09%, and up by 8.53% from previous year's revenue.

The company reported a net income of $1.40M, -97.13% lower than the previous year.

Amphastar Pharmaceuticals reported a free cash flow of $23.41M for its fiscal year, compared to $207.00K a year ago.

The company ended the fiscal year with $49.81M in total debt, a decrease of -1.00% compared to the previous year.